nodes	percent_of_prediction	percent_of_DWPC	metapath
Miconazole—NOS3—systemic scleroderma	0.563	1	CbGaD
Miconazole—CYP1A2—Pentoxifylline—systemic scleroderma	0.026	0.14	CbGbCtD
Miconazole—CYP1A2—Leflunomide—systemic scleroderma	0.0248	0.133	CbGbCtD
Miconazole—ABCB1—Lisinopril—systemic scleroderma	0.0227	0.122	CbGbCtD
Miconazole—CYP2C9—Leflunomide—systemic scleroderma	0.0223	0.12	CbGbCtD
Miconazole—ABCB1—Captopril—systemic scleroderma	0.017	0.0914	CbGbCtD
Miconazole—CYP2D6—Captopril—systemic scleroderma	0.016	0.0861	CbGbCtD
Miconazole—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0134	0.072	CbGbCtD
Miconazole—CYP2C19—Prednisone—systemic scleroderma	0.0133	0.0713	CbGbCtD
Miconazole—ABCB1—Prednisone—systemic scleroderma	0.0107	0.0575	CbGbCtD
Miconazole—KCNMB1—artery—systemic scleroderma	0.00847	0.0935	CbGeAlD
Miconazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00801	0.0431	CbGbCtD
Miconazole—NOS3—pulmonary artery—systemic scleroderma	0.00721	0.0796	CbGeAlD
Miconazole—KCNMB1—blood vessel—systemic scleroderma	0.0066	0.0728	CbGeAlD
Miconazole—CYP2C9—cardial valve—systemic scleroderma	0.00647	0.0714	CbGeAlD
Miconazole—CYP3A4—Prednisone—systemic scleroderma	0.00641	0.0345	CbGbCtD
Miconazole—KCNMA1—pulmonary artery—systemic scleroderma	0.00629	0.0694	CbGeAlD
Miconazole—ABCB1—Methotrexate—systemic scleroderma	0.00536	0.0289	CbGbCtD
Miconazole—NOS3—umbilical vein—systemic scleroderma	0.00476	0.0526	CbGeAlD
Miconazole—KCNMB1—smooth muscle tissue—systemic scleroderma	0.00309	0.0341	CbGeAlD
Miconazole—NOS3—artery—systemic scleroderma	0.00267	0.0295	CbGeAlD
Miconazole—NOS2—tendon—systemic scleroderma	0.00266	0.0294	CbGeAlD
Miconazole—KCNN3—smooth muscle tissue—systemic scleroderma	0.00254	0.028	CbGeAlD
Miconazole—KCNMA1—artery—systemic scleroderma	0.00233	0.0257	CbGeAlD
Miconazole—NOS3—endothelium—systemic scleroderma	0.00226	0.0249	CbGeAlD
Miconazole—KCNN2—smooth muscle tissue—systemic scleroderma	0.0021	0.0231	CbGeAlD
Miconazole—NOS3—blood vessel—systemic scleroderma	0.00208	0.023	CbGeAlD
Miconazole—KCNN2—skin of body—systemic scleroderma	0.00207	0.0229	CbGeAlD
Miconazole—KCNMB2—lung—systemic scleroderma	0.00193	0.0213	CbGeAlD
Miconazole—KCNN3—tendon—systemic scleroderma	0.00191	0.021	CbGeAlD
Miconazole—KCNMA1—blood vessel—systemic scleroderma	0.00182	0.02	CbGeAlD
Miconazole—KCNN3—lung—systemic scleroderma	0.00167	0.0185	CbGeAlD
Miconazole—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TNIP1—systemic scleroderma	0.00164	0.0392	CbGpPWpGaD
Miconazole—KCNMB4—lung—systemic scleroderma	0.00159	0.0176	CbGeAlD
Miconazole—KCNN2—tendon—systemic scleroderma	0.00158	0.0174	CbGeAlD
Miconazole—KCNN2—lung—systemic scleroderma	0.00138	0.0153	CbGeAlD
Miconazole—KCNMB4—Nitric oxide stimulates guanylate cyclase—NOS3—systemic scleroderma	0.00128	0.0306	CbGpPWpGaD
Miconazole—KCNMB2—Nitric oxide stimulates guanylate cyclase—NOS3—systemic scleroderma	0.00128	0.0306	CbGpPWpGaD
Miconazole—KCNMB3—Nitric oxide stimulates guanylate cyclase—NOS3—systemic scleroderma	0.00128	0.0306	CbGpPWpGaD
Miconazole—KCNMB1—Nitric oxide stimulates guanylate cyclase—NOS3—systemic scleroderma	0.00128	0.0306	CbGpPWpGaD
Miconazole—NOS2—Effects of Nitric Oxide—NOS3—systemic scleroderma	0.00113	0.0271	CbGpPWpGaD
Miconazole—KCNN4—smooth muscle tissue—systemic scleroderma	0.00111	0.0123	CbGeAlD
Miconazole—NOS3—connective tissue—systemic scleroderma	0.00107	0.0118	CbGeAlD
Miconazole—NOS2—Spinal Cord Injury—AIF1—systemic scleroderma	0.00104	0.0249	CbGpPWpGaD
Miconazole—NOS3—ACE Inhibitor Pathway—ACE—systemic scleroderma	0.00103	0.0248	CbGpPWpGaD
Miconazole—CYP51A1—lung—systemic scleroderma	0.00102	0.0112	CbGeAlD
Miconazole—CYP17A1—connective tissue—systemic scleroderma	0.00101	0.0111	CbGeAlD
Miconazole—NOS3—smooth muscle tissue—systemic scleroderma	0.000977	0.0108	CbGeAlD
Miconazole—KCNH6—lung—systemic scleroderma	0.000937	0.0103	CbGeAlD
Miconazole—NOS2—Type II interferon signaling (IFNG)—IRF8—systemic scleroderma	0.000916	0.0219	CbGpPWpGaD
Miconazole—KCNN4—digestive system—systemic scleroderma	0.000879	0.00971	CbGeAlD
Miconazole—KCNMA1—smooth muscle tissue—systemic scleroderma	0.000852	0.0094	CbGeAlD
Miconazole—KCNN4—tendon—systemic scleroderma	0.000837	0.00924	CbGeAlD
Miconazole—NOS2—IL23-mediated signaling events—STAT4—systemic scleroderma	0.000806	0.0193	CbGpPWpGaD
Miconazole—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—COL1A2—systemic scleroderma	0.000783	0.0188	CbGpPWpGaD
Miconazole—NOS3—digestive system—systemic scleroderma	0.000771	0.00851	CbGeAlD
Miconazole—KCNN4—lung—systemic scleroderma	0.000735	0.00811	CbGeAlD
Miconazole—NOS3—tendon—systemic scleroderma	0.000734	0.0081	CbGeAlD
Miconazole—KCNH2—Hematopoietic Stem Cell Differentiation—CSF1—systemic scleroderma	0.000686	0.0164	CbGpPWpGaD
Miconazole—NOS3—lung—systemic scleroderma	0.000644	0.00711	CbGeAlD
Miconazole—KCNH7—Circadian rythm related genes—TOP1—systemic scleroderma	0.000625	0.015	CbGpPWpGaD
Miconazole—NOS2—IL12-mediated signaling events—CD247—systemic scleroderma	0.000622	0.0149	CbGpPWpGaD
Miconazole—CYP19A1—connective tissue—systemic scleroderma	0.00061	0.00673	CbGeAlD
Miconazole—KCNMA1—lung—systemic scleroderma	0.000562	0.0062	CbGeAlD
Miconazole—NOS2—IL12-mediated signaling events—STAT4—systemic scleroderma	0.000548	0.0131	CbGpPWpGaD
Miconazole—KCNMA1—Nitric oxide stimulates guanylate cyclase—NOS3—systemic scleroderma	0.000527	0.0126	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—TNFSF13—systemic scleroderma	0.000508	0.0122	CbGpPWpGaD
Miconazole—KCNMB4—Platelet homeostasis—NOS3—systemic scleroderma	0.000497	0.0119	CbGpPWpGaD
Miconazole—KCNMB3—Platelet homeostasis—NOS3—systemic scleroderma	0.000497	0.0119	CbGpPWpGaD
Miconazole—KCNMB1—Platelet homeostasis—NOS3—systemic scleroderma	0.000497	0.0119	CbGpPWpGaD
Miconazole—KCNMB2—Platelet homeostasis—NOS3—systemic scleroderma	0.000497	0.0119	CbGpPWpGaD
Miconazole—NOS3—Thromboxane A2 receptor signaling—BLK—systemic scleroderma	0.000472	0.0113	CbGpPWpGaD
Miconazole—NOS2—Nitric oxide stimulates guanylate cyclase—NOS3—systemic scleroderma	0.00047	0.0113	CbGpPWpGaD
Miconazole—CYP2A6—lung—systemic scleroderma	0.000469	0.00518	CbGeAlD
Miconazole—NOS3—Endothelin Pathways—EDN1—systemic scleroderma	0.000465	0.0111	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—SELP—systemic scleroderma	0.000453	0.0109	CbGpPWpGaD
Miconazole—KCNMA1—Circadian rythm related genes—TOP1—systemic scleroderma	0.000449	0.0108	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—RHOB—systemic scleroderma	0.000423	0.0101	CbGpPWpGaD
Miconazole—ABCB1—blood vessel—systemic scleroderma	0.000408	0.00451	CbGeAlD
Miconazole—NOS2—Circadian rythm related genes—TOP1—systemic scleroderma	0.000401	0.0096	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—SELP—systemic scleroderma	0.000384	0.0092	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—SELP—systemic scleroderma	0.000384	0.0092	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—SELP—systemic scleroderma	0.000384	0.0092	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—SELP—systemic scleroderma	0.000384	0.0092	CbGpPWpGaD
Miconazole—NOS2—IL23-mediated signaling events—CCL2—systemic scleroderma	0.000373	0.00895	CbGpPWpGaD
Miconazole—Chills—Leflunomide—systemic scleroderma	0.000373	0.00315	CcSEcCtD
Miconazole—Discomfort—Captopril—systemic scleroderma	0.00037	0.00311	CcSEcCtD
Miconazole—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000366	0.00308	CcSEcCtD
Miconazole—Dry mouth—Captopril—systemic scleroderma	0.000366	0.00308	CcSEcCtD
Miconazole—CYP2C19—digestive system—systemic scleroderma	0.000361	0.00399	CbGeAlD
Miconazole—Anaphylactic shock—Captopril—systemic scleroderma	0.000359	0.00302	CcSEcCtD
Miconazole—KCNMB1—Hemostasis—RHOB—systemic scleroderma	0.000358	0.00859	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—RHOB—systemic scleroderma	0.000358	0.00859	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—RHOB—systemic scleroderma	0.000358	0.00859	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—RHOB—systemic scleroderma	0.000358	0.00859	CbGpPWpGaD
Miconazole—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.000358	0.00301	CcSEcCtD
Miconazole—Hepatitis—Lisinopril—systemic scleroderma	0.000357	0.00301	CcSEcCtD
Miconazole—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP1—systemic scleroderma	0.000356	0.00854	CbGpPWpGaD
Miconazole—Chills—Mycophenolic acid—systemic scleroderma	0.000356	0.003	CcSEcCtD
Miconazole—NOS2—Latent infection of Homo sapiens with Mycobacterium tuberculosis—NOS3—systemic scleroderma	0.000356	0.00853	CbGpPWpGaD
Miconazole—Ill-defined disorder—Azathioprine—systemic scleroderma	0.000356	0.003	CcSEcCtD
Miconazole—Decreased appetite—Mometasone—systemic scleroderma	0.000355	0.00299	CcSEcCtD
Miconazole—Dysgeusia—Leflunomide—systemic scleroderma	0.000355	0.00299	CcSEcCtD
Miconazole—Anaemia—Azathioprine—systemic scleroderma	0.000354	0.00299	CcSEcCtD
Miconazole—CYP2B6—skin of body—systemic scleroderma	0.000354	0.0039	CbGeAlD
Miconazole—Fatigue—Mometasone—systemic scleroderma	0.000352	0.00297	CcSEcCtD
Miconazole—Pain—Mometasone—systemic scleroderma	0.000349	0.00294	CcSEcCtD
Miconazole—Infestation—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00294	CcSEcCtD
Miconazole—Infestation NOS—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00294	CcSEcCtD
Miconazole—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000349	0.00294	CcSEcCtD
Miconazole—Muscle spasms—Leflunomide—systemic scleroderma	0.000348	0.00293	CcSEcCtD
Miconazole—Malaise—Azathioprine—systemic scleroderma	0.000346	0.00291	CcSEcCtD
Miconazole—NOS2—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	0.000344	0.00824	CbGpPWpGaD
Miconazole—Anorexia—Captopril—systemic scleroderma	0.000342	0.00288	CcSEcCtD
Miconazole—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00287	CcSEcCtD
Miconazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—systemic scleroderma	0.000339	0.00814	CbGpPWpGaD
Miconazole—Asthenia—Pentoxifylline—systemic scleroderma	0.000339	0.00286	CcSEcCtD
Miconazole—Erythema multiforme—Lisinopril—systemic scleroderma	0.000338	0.00285	CcSEcCtD
Miconazole—KCNH2—Hematopoietic Stem Cell Differentiation—IL1A—systemic scleroderma	0.000337	0.00807	CbGpPWpGaD
Miconazole—Ill-defined disorder—Leflunomide—systemic scleroderma	0.000336	0.00283	CcSEcCtD
Miconazole—Pruritus—Pentoxifylline—systemic scleroderma	0.000335	0.00282	CcSEcCtD
Miconazole—Anaemia—Leflunomide—systemic scleroderma	0.000335	0.00282	CcSEcCtD
Miconazole—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000334	0.00281	CcSEcCtD
Miconazole—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000332	0.0028	CcSEcCtD
Miconazole—Angioedema—Leflunomide—systemic scleroderma	0.000331	0.00279	CcSEcCtD
Miconazole—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.00033	0.00278	CcSEcCtD
Miconazole—Malaise—Leflunomide—systemic scleroderma	0.000327	0.00275	CcSEcCtD
Miconazole—KCNMB4—Hemostasis—CSK—systemic scleroderma	0.000326	0.00782	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—CSK—systemic scleroderma	0.000326	0.00782	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—CSK—systemic scleroderma	0.000326	0.00782	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—CSK—systemic scleroderma	0.000326	0.00782	CbGpPWpGaD
Miconazole—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000324	0.00273	CcSEcCtD
Miconazole—Abdominal pain—Mometasone—systemic scleroderma	0.000323	0.00272	CcSEcCtD
Miconazole—Discomfort—Azathioprine—systemic scleroderma	0.000322	0.00272	CcSEcCtD
Miconazole—Mediastinal disorder—Lisinopril—systemic scleroderma	0.000322	0.00271	CcSEcCtD
Miconazole—Chills—Lisinopril—systemic scleroderma	0.000321	0.0027	CcSEcCtD
Miconazole—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00032	0.0027	CcSEcCtD
Miconazole—Mouth ulceration—Methotrexate—systemic scleroderma	0.000319	0.00269	CcSEcCtD
Miconazole—Anaemia—Mycophenolic acid—systemic scleroderma	0.000319	0.00269	CcSEcCtD
Miconazole—NOS3—ACE Inhibitor Pathway—TGFB1—systemic scleroderma	0.000318	0.00763	CbGpPWpGaD
Miconazole—Cough—Leflunomide—systemic scleroderma	0.000316	0.00266	CcSEcCtD
Miconazole—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000313	0.00264	CcSEcCtD
Miconazole—Decreased appetite—Captopril—systemic scleroderma	0.000312	0.00263	CcSEcCtD
Miconazole—Malaise—Mycophenolic acid—systemic scleroderma	0.000311	0.00262	CcSEcCtD
Miconazole—Infection—Azathioprine—systemic scleroderma	0.000311	0.00262	CcSEcCtD
Miconazole—Fatigue—Captopril—systemic scleroderma	0.000309	0.0026	CcSEcCtD
Miconazole—KCNMB1—Hemostasis—ITGAM—systemic scleroderma	0.000307	0.00735	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—ITGAM—systemic scleroderma	0.000307	0.00735	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—ITGAM—systemic scleroderma	0.000307	0.00735	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—ITGAM—systemic scleroderma	0.000307	0.00735	CbGpPWpGaD
Miconazole—Dysgeusia—Lisinopril—systemic scleroderma	0.000305	0.00257	CcSEcCtD
Miconazole—Discomfort—Leflunomide—systemic scleroderma	0.000305	0.00257	CcSEcCtD
Miconazole—Dry mouth—Leflunomide—systemic scleroderma	0.000301	0.00254	CcSEcCtD
Miconazole—Cough—Mycophenolic acid—systemic scleroderma	0.000301	0.00254	CcSEcCtD
Miconazole—Vomiting—Pentoxifylline—systemic scleroderma	0.000301	0.00253	CcSEcCtD
Miconazole—Muscle spasms—Lisinopril—systemic scleroderma	0.000299	0.00252	CcSEcCtD
Miconazole—Rash—Pentoxifylline—systemic scleroderma	0.000298	0.00251	CcSEcCtD
Miconazole—Dermatitis—Pentoxifylline—systemic scleroderma	0.000298	0.00251	CcSEcCtD
Miconazole—Headache—Pentoxifylline—systemic scleroderma	0.000296	0.0025	CcSEcCtD
Miconazole—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000295	0.00249	CcSEcCtD
Miconazole—Feeling abnormal—Captopril—systemic scleroderma	0.000295	0.00249	CcSEcCtD
Miconazole—CYP1A2—digestive system—systemic scleroderma	0.000295	0.00326	CbGeAlD
Miconazole—Infection—Leflunomide—systemic scleroderma	0.000294	0.00247	CcSEcCtD
Miconazole—Gastrointestinal pain—Captopril—systemic scleroderma	0.000293	0.00247	CcSEcCtD
Miconazole—NOS3—Angiogenesis—MMP9—systemic scleroderma	0.000293	0.00702	CbGpPWpGaD
Miconazole—Asthenia—Mometasone—systemic scleroderma	0.000293	0.00247	CcSEcCtD
Miconazole—Discomfort—Mycophenolic acid—systemic scleroderma	0.000291	0.00245	CcSEcCtD
Miconazole—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—systemic scleroderma	0.00029	0.00695	CbGpPWpGaD
Miconazole—Nervous system disorder—Leflunomide—systemic scleroderma	0.00029	0.00244	CcSEcCtD
Miconazole—Pruritus—Mometasone—systemic scleroderma	0.000289	0.00243	CcSEcCtD
Miconazole—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000289	0.00243	CcSEcCtD
Miconazole—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000288	0.00242	CcSEcCtD
Miconazole—Anaemia—Lisinopril—systemic scleroderma	0.000288	0.00242	CcSEcCtD
Miconazole—Angioedema—Lisinopril—systemic scleroderma	0.000284	0.0024	CcSEcCtD
Miconazole—Abdominal pain—Captopril—systemic scleroderma	0.000283	0.00239	CcSEcCtD
Miconazole—NOS2—Type II interferon signaling (IFNG)—IL1B—systemic scleroderma	0.000283	0.00679	CbGpPWpGaD
Miconazole—NOS2—IL23-mediated signaling events—IL1B—systemic scleroderma	0.000283	0.00679	CbGpPWpGaD
Miconazole—CYP2B6—digestive system—systemic scleroderma	0.000283	0.00312	CbGeAlD
Miconazole—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00238	CcSEcCtD
Miconazole—Anorexia—Leflunomide—systemic scleroderma	0.000282	0.00237	CcSEcCtD
Miconazole—Nausea—Pentoxifylline—systemic scleroderma	0.000281	0.00237	CcSEcCtD
Miconazole—Chills—Mycophenolate mofetil—systemic scleroderma	0.000281	0.00237	CcSEcCtD
Miconazole—Malaise—Lisinopril—systemic scleroderma	0.000281	0.00236	CcSEcCtD
Miconazole—CYP2C9—digestive system—systemic scleroderma	0.00028	0.00309	CbGeAlD
Miconazole—Infection—Mycophenolic acid—systemic scleroderma	0.00028	0.00236	CcSEcCtD
Miconazole—Diarrhoea—Mometasone—systemic scleroderma	0.000279	0.00235	CcSEcCtD
Miconazole—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000276	0.00233	CcSEcCtD
Miconazole—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—systemic scleroderma	0.000276	0.00661	CbGpPWpGaD
Miconazole—Cough—Lisinopril—systemic scleroderma	0.000271	0.00229	CcSEcCtD
Miconazole—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00027	0.00228	CcSEcCtD
Miconazole—Anorexia—Mycophenolic acid—systemic scleroderma	0.000269	0.00226	CcSEcCtD
Miconazole—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000267	0.00225	CcSEcCtD
Miconazole—CYP2E1—digestive system—systemic scleroderma	0.000265	0.00293	CbGeAlD
Miconazole—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000262	0.00221	CcSEcCtD
Miconazole—Discomfort—Lisinopril—systemic scleroderma	0.000262	0.00221	CcSEcCtD
Miconazole—Vomiting—Mometasone—systemic scleroderma	0.00026	0.00219	CcSEcCtD
Miconazole—Dry mouth—Lisinopril—systemic scleroderma	0.000259	0.00218	CcSEcCtD
Miconazole—Feeling abnormal—Azathioprine—systemic scleroderma	0.000258	0.00217	CcSEcCtD
Miconazole—Rash—Mometasone—systemic scleroderma	0.000257	0.00217	CcSEcCtD
Miconazole—Asthenia—Captopril—systemic scleroderma	0.000257	0.00217	CcSEcCtD
Miconazole—Dermatitis—Mometasone—systemic scleroderma	0.000257	0.00217	CcSEcCtD
Miconazole—Decreased appetite—Leflunomide—systemic scleroderma	0.000257	0.00216	CcSEcCtD
Miconazole—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000256	0.00216	CcSEcCtD
Miconazole—Headache—Mometasone—systemic scleroderma	0.000256	0.00216	CcSEcCtD
Miconazole—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000255	0.00215	CcSEcCtD
Miconazole—Fatigue—Leflunomide—systemic scleroderma	0.000255	0.00215	CcSEcCtD
Miconazole—NOS3—Plasma membrane estrogen receptor signaling—MMP2—systemic scleroderma	0.000254	0.00609	CbGpPWpGaD
Miconazole—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000254	0.00214	CcSEcCtD
Miconazole—Pruritus—Captopril—systemic scleroderma	0.000254	0.00214	CcSEcCtD
Miconazole—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00213	CcSEcCtD
Miconazole—Pain—Leflunomide—systemic scleroderma	0.000253	0.00213	CcSEcCtD
Miconazole—CYP2E1—tendon—systemic scleroderma	0.000253	0.00279	CbGeAlD
Miconazole—Infection—Lisinopril—systemic scleroderma	0.000252	0.00213	CcSEcCtD
Miconazole—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000252	0.00212	CcSEcCtD
Miconazole—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000249	0.0021	CcSEcCtD
Miconazole—Neutropenia—Prednisone—systemic scleroderma	0.000248	0.00209	CcSEcCtD
Miconazole—Abdominal pain—Azathioprine—systemic scleroderma	0.000247	0.00208	CcSEcCtD
Miconazole—CYP1A2—lung—systemic scleroderma	0.000246	0.00272	CbGeAlD
Miconazole—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000246	0.00207	CcSEcCtD
Miconazole—Diarrhoea—Captopril—systemic scleroderma	0.000245	0.00207	CcSEcCtD
Miconazole—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000245	0.00207	CcSEcCtD
Miconazole—NOS2—ATF-2 transcription factor network—MMP2—systemic scleroderma	0.000245	0.00586	CbGpPWpGaD
Miconazole—Feeling abnormal—Leflunomide—systemic scleroderma	0.000244	0.00205	CcSEcCtD
Miconazole—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000243	0.00205	CcSEcCtD
Miconazole—Fatigue—Mycophenolic acid—systemic scleroderma	0.000243	0.00205	CcSEcCtD
Miconazole—Nausea—Mometasone—systemic scleroderma	0.000242	0.00204	CcSEcCtD
Miconazole—Anorexia—Lisinopril—systemic scleroderma	0.000242	0.00204	CcSEcCtD
Miconazole—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000242	0.00204	CcSEcCtD
Miconazole—Pain—Mycophenolic acid—systemic scleroderma	0.000241	0.00203	CcSEcCtD
Miconazole—Cough—Mycophenolate mofetil—systemic scleroderma	0.000238	0.002	CcSEcCtD
Miconazole—CYP2B6—lung—systemic scleroderma	0.000236	0.00261	CbGeAlD
Miconazole—Urticaria—Leflunomide—systemic scleroderma	0.000235	0.00198	CcSEcCtD
Miconazole—Abdominal pain—Leflunomide—systemic scleroderma	0.000234	0.00197	CcSEcCtD
Miconazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000232	0.00196	CcSEcCtD
Miconazole—NOS3—EGF/EGFR Signaling Pathway—CSK—systemic scleroderma	0.000232	0.00556	CbGpPWpGaD
Miconazole—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000231	0.00195	CcSEcCtD
Miconazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000231	0.00194	CcSEcCtD
Miconazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000231	0.00194	CcSEcCtD
Miconazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000229	0.00193	CcSEcCtD
Miconazole—Vomiting—Captopril—systemic scleroderma	0.000228	0.00192	CcSEcCtD
Miconazole—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00191	CcSEcCtD
Miconazole—Rash—Captopril—systemic scleroderma	0.000226	0.00191	CcSEcCtD
Miconazole—Dermatitis—Captopril—systemic scleroderma	0.000226	0.0019	CcSEcCtD
Miconazole—Headache—Captopril—systemic scleroderma	0.000225	0.00189	CcSEcCtD
Miconazole—NOS2—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000224	0.00536	CbGpPWpGaD
Miconazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000223	0.00188	CcSEcCtD
Miconazole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00187	CcSEcCtD
Miconazole—CYP2E1—lung—systemic scleroderma	0.000222	0.00245	CbGeAlD
Miconazole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000221	0.00186	CcSEcCtD
Miconazole—Decreased appetite—Lisinopril—systemic scleroderma	0.000221	0.00186	CcSEcCtD
Miconazole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000219	0.00185	CcSEcCtD
Miconazole—Fatigue—Lisinopril—systemic scleroderma	0.000219	0.00184	CcSEcCtD
Miconazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00184	CcSEcCtD
Miconazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.000218	0.00183	CcSEcCtD
Miconazole—Pain—Lisinopril—systemic scleroderma	0.000217	0.00183	CcSEcCtD
Miconazole—NOS3—Angiopoietin receptor Tie2-mediated signaling—MMP2—systemic scleroderma	0.000217	0.00519	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—IL1A—systemic scleroderma	0.000215	0.00514	CbGpPWpGaD
Miconazole—Diarrhoea—Azathioprine—systemic scleroderma	0.000214	0.0018	CcSEcCtD
Miconazole—CYP3A4—digestive system—systemic scleroderma	0.000214	0.00236	CbGeAlD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—SMAD7—systemic scleroderma	0.000213	0.00511	CbGpPWpGaD
Miconazole—Nausea—Captopril—systemic scleroderma	0.000213	0.00179	CcSEcCtD
Miconazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000212	0.00179	CcSEcCtD
Miconazole—Asthenia—Leflunomide—systemic scleroderma	0.000212	0.00179	CcSEcCtD
Miconazole—CYP2D6—digestive system—systemic scleroderma	0.00021	0.00232	CbGeAlD
Miconazole—NOS2—AGE/RAGE pathway—NOS3—systemic scleroderma	0.000209	0.00502	CbGpPWpGaD
Miconazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.000209	0.00176	CcSEcCtD
Miconazole—Pruritus—Leflunomide—systemic scleroderma	0.000209	0.00176	CcSEcCtD
Miconazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000208	0.00175	CcSEcCtD
Miconazole—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—systemic scleroderma	0.000207	0.00497	CbGpPWpGaD
Miconazole—Neutropenia—Methotrexate—systemic scleroderma	0.000207	0.00175	CcSEcCtD
Miconazole—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000206	0.00174	CcSEcCtD
Miconazole—KCNMA1—Platelet homeostasis—NOS3—systemic scleroderma	0.000205	0.00492	CbGpPWpGaD
Miconazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000202	0.0017	CcSEcCtD
Miconazole—Diarrhoea—Leflunomide—systemic scleroderma	0.000202	0.0017	CcSEcCtD
Miconazole—Urticaria—Lisinopril—systemic scleroderma	0.000202	0.0017	CcSEcCtD
Miconazole—Abdominal pain—Lisinopril—systemic scleroderma	0.000201	0.00169	CcSEcCtD
Miconazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000199	0.00168	CcSEcCtD
Miconazole—Vomiting—Azathioprine—systemic scleroderma	0.000199	0.00168	CcSEcCtD
Miconazole—Infestation NOS—Methotrexate—systemic scleroderma	0.000198	0.00167	CcSEcCtD
Miconazole—Infestation—Methotrexate—systemic scleroderma	0.000198	0.00167	CcSEcCtD
Miconazole—Rash—Azathioprine—systemic scleroderma	0.000197	0.00166	CcSEcCtD
Miconazole—Dermatitis—Azathioprine—systemic scleroderma	0.000197	0.00166	CcSEcCtD
Miconazole—Headache—Azathioprine—systemic scleroderma	0.000196	0.00165	CcSEcCtD
Miconazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000196	0.00165	CcSEcCtD
Miconazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000193	0.00163	CcSEcCtD
Miconazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000193	0.00163	CcSEcCtD
Miconazole—Stomatitis—Methotrexate—systemic scleroderma	0.000193	0.00162	CcSEcCtD
Miconazole—NOS2—IL12-mediated signaling events—IL1B—systemic scleroderma	0.000192	0.00461	CbGpPWpGaD
Miconazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000192	0.00162	CcSEcCtD
Miconazole—Immune system disorder—Prednisone—systemic scleroderma	0.000192	0.00162	CcSEcCtD
Miconazole—NOS3—Plasma membrane estrogen receptor signaling—MMP9—systemic scleroderma	0.000191	0.00458	CbGpPWpGaD
Miconazole—Pain—Mycophenolate mofetil—systemic scleroderma	0.00019	0.0016	CcSEcCtD
Miconazole—Vomiting—Leflunomide—systemic scleroderma	0.000188	0.00158	CcSEcCtD
Miconazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000187	0.00158	CcSEcCtD
Miconazole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000187	0.00157	CcSEcCtD
Miconazole—Rash—Leflunomide—systemic scleroderma	0.000186	0.00157	CcSEcCtD
Miconazole—Dermatitis—Leflunomide—systemic scleroderma	0.000186	0.00157	CcSEcCtD
Miconazole—Nausea—Azathioprine—systemic scleroderma	0.000186	0.00157	CcSEcCtD
Miconazole—Headache—Leflunomide—systemic scleroderma	0.000185	0.00156	CcSEcCtD
Miconazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00154	CcSEcCtD
Miconazole—NOS2—Platelet homeostasis—NOS3—systemic scleroderma	0.000183	0.00439	CbGpPWpGaD
Miconazole—Asthenia—Lisinopril—systemic scleroderma	0.000182	0.00154	CcSEcCtD
Miconazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000182	0.00153	CcSEcCtD
Miconazole—KCNH2—SIDS Susceptibility Pathways—IL13—systemic scleroderma	0.00018	0.00432	CbGpPWpGaD
Miconazole—Pruritus—Lisinopril—systemic scleroderma	0.00018	0.00151	CcSEcCtD
Miconazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000179	0.00151	CcSEcCtD
Miconazole—Rash—Mycophenolic acid—systemic scleroderma	0.000178	0.0015	CcSEcCtD
Miconazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000178	0.0015	CcSEcCtD
Miconazole—Hepatitis—Methotrexate—systemic scleroderma	0.000177	0.00149	CcSEcCtD
Miconazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000177	0.00149	CcSEcCtD
Miconazole—Headache—Mycophenolic acid—systemic scleroderma	0.000177	0.00149	CcSEcCtD
Miconazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00148	CcSEcCtD
Miconazole—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—systemic scleroderma	0.000176	0.00421	CbGpPWpGaD
Miconazole—Nausea—Leflunomide—systemic scleroderma	0.000176	0.00148	CcSEcCtD
Miconazole—Diarrhoea—Lisinopril—systemic scleroderma	0.000174	0.00146	CcSEcCtD
Miconazole—NOS3—AGE/RAGE pathway—MMP2—systemic scleroderma	0.000174	0.00416	CbGpPWpGaD
Miconazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.000171	0.00144	CcSEcCtD
Miconazole—Anaemia—Prednisone—systemic scleroderma	0.000171	0.00144	CcSEcCtD
Miconazole—Angioedema—Prednisone—systemic scleroderma	0.000169	0.00142	CcSEcCtD
Miconazole—NOS2—AGE/RAGE pathway—MMP9—systemic scleroderma	0.000168	0.00403	CbGpPWpGaD
Miconazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000168	0.00141	CcSEcCtD
Miconazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000167	0.00141	CcSEcCtD
Miconazole—Malaise—Prednisone—systemic scleroderma	0.000167	0.0014	CcSEcCtD
Miconazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000164	0.00138	CcSEcCtD
Miconazole—Vomiting—Lisinopril—systemic scleroderma	0.000161	0.00136	CcSEcCtD
Miconazole—Immune system disorder—Methotrexate—systemic scleroderma	0.00016	0.00135	CcSEcCtD
Miconazole—Rash—Lisinopril—systemic scleroderma	0.00016	0.00135	CcSEcCtD
Miconazole—Dermatitis—Lisinopril—systemic scleroderma	0.00016	0.00135	CcSEcCtD
Miconazole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00016	0.00135	CcSEcCtD
Miconazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.00135	CcSEcCtD
Miconazole—Chills—Methotrexate—systemic scleroderma	0.000159	0.00134	CcSEcCtD
Miconazole—Headache—Lisinopril—systemic scleroderma	0.000159	0.00134	CcSEcCtD
Miconazole—KCNMA1—Hemostasis—SELP—systemic scleroderma	0.000158	0.00379	CbGpPWpGaD
Miconazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000157	0.00133	CcSEcCtD
Miconazole—Discomfort—Prednisone—systemic scleroderma	0.000155	0.00131	CcSEcCtD
Miconazole—KCNMB4—Hemostasis—MMP1—systemic scleroderma	0.000154	0.00368	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—MMP1—systemic scleroderma	0.000154	0.00368	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—MMP1—systemic scleroderma	0.000154	0.00368	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—MMP1—systemic scleroderma	0.000154	0.00368	CbGpPWpGaD
Miconazole—CYP2C19—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000153	0.00367	CbGpPWpGaD
Miconazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000152	0.00128	CcSEcCtD
Miconazole—Dysgeusia—Methotrexate—systemic scleroderma	0.000151	0.00127	CcSEcCtD
Miconazole—ABCB1—digestive system—systemic scleroderma	0.000151	0.00167	CbGeAlD
Miconazole—Nausea—Lisinopril—systemic scleroderma	0.000151	0.00127	CcSEcCtD
Miconazole—Anaphylactic shock—Prednisone—systemic scleroderma	0.000151	0.00127	CcSEcCtD
Miconazole—Infection—Prednisone—systemic scleroderma	0.00015	0.00126	CcSEcCtD
Miconazole—Nervous system disorder—Prednisone—systemic scleroderma	0.000148	0.00125	CcSEcCtD
Miconazole—KCNMA1—Hemostasis—RHOB—systemic scleroderma	0.000148	0.00354	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—CCL2—systemic scleroderma	0.000148	0.00354	CbGpPWpGaD
Miconazole—Anorexia—Prednisone—systemic scleroderma	0.000144	0.00121	CcSEcCtD
Miconazole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000143	0.00121	CcSEcCtD
Miconazole—Anaemia—Methotrexate—systemic scleroderma	0.000143	0.0012	CcSEcCtD
Miconazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000141	0.00119	CcSEcCtD
Miconazole—NOS2—Hemostasis—SELP—systemic scleroderma	0.000141	0.00339	CbGpPWpGaD
Miconazole—CYP2D6—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000141	0.00337	CbGpPWpGaD
Miconazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00118	CcSEcCtD
Miconazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00014	0.00118	CcSEcCtD
Miconazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000139	0.00117	CcSEcCtD
Miconazole—Malaise—Methotrexate—systemic scleroderma	0.000139	0.00117	CcSEcCtD
Miconazole—Cough—Methotrexate—systemic scleroderma	0.000135	0.00114	CcSEcCtD
Miconazole—KCNMA1—Hemostasis—CSK—systemic scleroderma	0.000135	0.00323	CbGpPWpGaD
Miconazole—CYP11B1—Corticotropin-releasing hormone—NOS3—systemic scleroderma	0.000135	0.00323	CbGpPWpGaD
Miconazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000132	0.00111	CcSEcCtD
Miconazole—NOS2—Hemostasis—RHOB—systemic scleroderma	0.000132	0.00316	CbGpPWpGaD
Miconazole—Decreased appetite—Prednisone—systemic scleroderma	0.000131	0.0011	CcSEcCtD
Miconazole—NOS3—AGE/RAGE pathway—MMP9—systemic scleroderma	0.00013	0.00313	CbGpPWpGaD
Miconazole—Fatigue—Prednisone—systemic scleroderma	0.00013	0.0011	CcSEcCtD
Miconazole—Discomfort—Methotrexate—systemic scleroderma	0.00013	0.00109	CcSEcCtD
Miconazole—KCNMA1—Hemostasis—ITGAM—systemic scleroderma	0.000127	0.00303	CbGpPWpGaD
Miconazole—ABCB1—lung—systemic scleroderma	0.000126	0.00139	CbGeAlD
Miconazole—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000126	0.00106	CcSEcCtD
Miconazole—Infection—Methotrexate—systemic scleroderma	0.000125	0.00106	CcSEcCtD
Miconazole—NOS3—Leptin signaling pathway—IL1B—systemic scleroderma	0.000125	0.00299	CbGpPWpGaD
Miconazole—Feeling abnormal—Prednisone—systemic scleroderma	0.000124	0.00105	CcSEcCtD
Miconazole—Nervous system disorder—Methotrexate—systemic scleroderma	0.000124	0.00104	CcSEcCtD
Miconazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000123	0.00104	CcSEcCtD
Miconazole—NOS2—Hemostasis—CSK—systemic scleroderma	0.00012	0.00288	CbGpPWpGaD
Miconazole—Anorexia—Methotrexate—systemic scleroderma	0.00012	0.00101	CcSEcCtD
Miconazole—Urticaria—Prednisone—systemic scleroderma	0.00012	0.00101	CcSEcCtD
Miconazole—CYP1A2—Melatonin metabolism and effects—EDN1—systemic scleroderma	0.000119	0.00286	CbGpPWpGaD
Miconazole—Abdominal pain—Prednisone—systemic scleroderma	0.000119	0.001	CcSEcCtD
Miconazole—KCNH2—SIDS Susceptibility Pathways—IL1A—systemic scleroderma	0.000113	0.00272	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—ITGAM—systemic scleroderma	0.000113	0.00271	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—IL1B—systemic scleroderma	0.000112	0.00268	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—NOS3—systemic scleroderma	0.000111	0.00267	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—NOS3—systemic scleroderma	0.000111	0.00267	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—NOS3—systemic scleroderma	0.000111	0.00267	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—NOS3—systemic scleroderma	0.000111	0.00267	CbGpPWpGaD
Miconazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000111	0.000936	CcSEcCtD
Miconazole—NOS3—Hemostasis—SELP—systemic scleroderma	0.00011	0.00263	CbGpPWpGaD
Miconazole—Decreased appetite—Methotrexate—systemic scleroderma	0.00011	0.000923	CcSEcCtD
Miconazole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000109	0.000917	CcSEcCtD
Miconazole—Fatigue—Methotrexate—systemic scleroderma	0.000109	0.000916	CcSEcCtD
Miconazole—Asthenia—Prednisone—systemic scleroderma	0.000108	0.000912	CcSEcCtD
Miconazole—Pain—Methotrexate—systemic scleroderma	0.000108	0.000908	CcSEcCtD
Miconazole—Pruritus—Prednisone—systemic scleroderma	0.000107	0.000899	CcSEcCtD
Miconazole—ABCB1—Allograft Rejection—IL13—systemic scleroderma	0.000106	0.00254	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—MMP9—systemic scleroderma	0.000106	0.00253	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	0.000105	0.0025	CbGpPWpGaD
Miconazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.000104	0.000875	CcSEcCtD
Miconazole—Diarrhoea—Prednisone—systemic scleroderma	0.000103	0.00087	CcSEcCtD
Miconazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000103	0.000868	CcSEcCtD
Miconazole—NOS3—Hemostasis—RHOB—systemic scleroderma	0.000102	0.00246	CbGpPWpGaD
Miconazole—Urticaria—Methotrexate—systemic scleroderma	0.0001	0.000844	CcSEcCtD
Miconazole—Abdominal pain—Methotrexate—systemic scleroderma	9.96e-05	0.00084	CcSEcCtD
Miconazole—Vomiting—Prednisone—systemic scleroderma	9.59e-05	0.000808	CcSEcCtD
Miconazole—Rash—Prednisone—systemic scleroderma	9.51e-05	0.000801	CcSEcCtD
Miconazole—CYP11B1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	9.5e-05	0.00228	CbGpPWpGaD
Miconazole—Dermatitis—Prednisone—systemic scleroderma	9.5e-05	0.000801	CcSEcCtD
Miconazole—Headache—Prednisone—systemic scleroderma	9.45e-05	0.000796	CcSEcCtD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TOP1—systemic scleroderma	9.39e-05	0.00225	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—CSK—systemic scleroderma	9.33e-05	0.00224	CbGpPWpGaD
Miconazole—Hypersensitivity—Methotrexate—systemic scleroderma	9.29e-05	0.000782	CcSEcCtD
Miconazole—Asthenia—Methotrexate—systemic scleroderma	9.04e-05	0.000762	CcSEcCtD
Miconazole—Nausea—Prednisone—systemic scleroderma	8.96e-05	0.000755	CcSEcCtD
Miconazole—Pruritus—Methotrexate—systemic scleroderma	8.92e-05	0.000751	CcSEcCtD
Miconazole—CYP11B1—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	8.9e-05	0.00213	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	8.89e-05	0.00213	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—ITGAM—systemic scleroderma	8.77e-05	0.0021	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—TGFB1—systemic scleroderma	8.7e-05	0.00208	CbGpPWpGaD
Miconazole—Diarrhoea—Methotrexate—systemic scleroderma	8.62e-05	0.000727	CcSEcCtD
Miconazole—ABCB1—Allograft Rejection—CTLA4—systemic scleroderma	8.52e-05	0.00204	CbGpPWpGaD
Miconazole—NOS2—Disease—SMAD7—systemic scleroderma	8.26e-05	0.00198	CbGpPWpGaD
Miconazole—NOS3—Corticotropin-releasing hormone—TGFB1—systemic scleroderma	8.24e-05	0.00198	CbGpPWpGaD
Miconazole—Vomiting—Methotrexate—systemic scleroderma	8.01e-05	0.000675	CcSEcCtD
Miconazole—Rash—Methotrexate—systemic scleroderma	7.95e-05	0.00067	CcSEcCtD
Miconazole—Dermatitis—Methotrexate—systemic scleroderma	7.94e-05	0.000669	CcSEcCtD
Miconazole—CYP51A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	7.92e-05	0.0019	CbGpPWpGaD
Miconazole—Headache—Methotrexate—systemic scleroderma	7.9e-05	0.000665	CcSEcCtD
Miconazole—ABCB1—HIF-1-alpha transcription factor network—EDN1—systemic scleroderma	7.74e-05	0.00185	CbGpPWpGaD
Miconazole—NOS2—Disease—TGFBI—systemic scleroderma	7.55e-05	0.00181	CbGpPWpGaD
Miconazole—Nausea—Methotrexate—systemic scleroderma	7.49e-05	0.000631	CcSEcCtD
Miconazole—KCNMB2—Hemostasis—TGFB1—systemic scleroderma	7.37e-05	0.00177	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—TGFB1—systemic scleroderma	7.37e-05	0.00177	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—TGFB1—systemic scleroderma	7.37e-05	0.00177	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—TGFB1—systemic scleroderma	7.37e-05	0.00177	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	7.2e-05	0.00173	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—systemic scleroderma	7.08e-05	0.0017	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—HLA-DQB1—systemic scleroderma	7.01e-05	0.00168	CbGpPWpGaD
Miconazole—NOS3—Myometrial Relaxation and Contraction Pathways—IL1B—systemic scleroderma	6.99e-05	0.00167	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	6.73e-05	0.00161	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—IL1A—systemic scleroderma	6.66e-05	0.0016	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—CD40LG—systemic scleroderma	6.62e-05	0.00159	CbGpPWpGaD
Miconazole—NOS3—Disease—SMAD7—systemic scleroderma	6.41e-05	0.00154	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—MMP1—systemic scleroderma	6.34e-05	0.00152	CbGpPWpGaD
Miconazole—NOS2—Disease—HSPG2—systemic scleroderma	6.02e-05	0.00144	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—IL1B—systemic scleroderma	5.91e-05	0.00142	CbGpPWpGaD
Miconazole—NOS3—Disease—TGFBI—systemic scleroderma	5.86e-05	0.00141	CbGpPWpGaD
Miconazole—NOS2—Disease—CSK—systemic scleroderma	5.82e-05	0.00139	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—MMP1—systemic scleroderma	5.66e-05	0.00136	CbGpPWpGaD
Miconazole—NOS2—Disease—CD247—systemic scleroderma	5.47e-05	0.00131	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	5.38e-05	0.00129	CbGpPWpGaD
Miconazole—NOS3—Disease—HSPG2—systemic scleroderma	4.68e-05	0.00112	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—HSPG2—systemic scleroderma	4.65e-05	0.00112	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—NOS3—systemic scleroderma	4.6e-05	0.0011	CbGpPWpGaD
Miconazole—NOS3—Disease—CSK—systemic scleroderma	4.52e-05	0.00108	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—SMAD7—systemic scleroderma	4.49e-05	0.00108	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—MMP1—systemic scleroderma	4.4e-05	0.00105	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—systemic scleroderma	4.27e-05	0.00102	CbGpPWpGaD
Miconazole—NOS3—Disease—CD247—systemic scleroderma	4.25e-05	0.00102	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—HSPG2—systemic scleroderma	4.23e-05	0.00101	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—NOS3—systemic scleroderma	4.1e-05	0.000984	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	4.08e-05	0.000978	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—HSPG2—systemic scleroderma	3.96e-05	0.000948	CbGpPWpGaD
Miconazole—NOS3—Metabolism—HSPG2—systemic scleroderma	3.92e-05	0.000939	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—CTGF—systemic scleroderma	3.53e-05	0.000845	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—IL1B—systemic scleroderma	3.47e-05	0.000832	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—RHOB—systemic scleroderma	3.47e-05	0.000832	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic scleroderma	3.32e-05	0.000796	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—HSPG2—systemic scleroderma	3.28e-05	0.000785	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—CTGF—systemic scleroderma	3.21e-05	0.000768	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—CSK—systemic scleroderma	3.16e-05	0.000758	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—TGFB1—systemic scleroderma	3.04e-05	0.000729	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—CTGF—systemic scleroderma	3e-05	0.000719	CbGpPWpGaD
Miconazole—NOS3—Metabolism—CTGF—systemic scleroderma	2.97e-05	0.000712	CbGpPWpGaD
Miconazole—CYP2A6—NRF2 pathway—TGFB1—systemic scleroderma	2.78e-05	0.000665	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—TGFB1—systemic scleroderma	2.71e-05	0.000651	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—TGFB1—systemic scleroderma	2.7e-05	0.000647	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.61e-05	0.000626	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—HSPG2—systemic scleroderma	2.4e-05	0.000575	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.38e-05	0.000571	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—TGFB1—systemic scleroderma	2.11e-05	0.000505	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.04e-05	0.000488	CbGpPWpGaD
Miconazole—NOS2—Disease—NOS3—systemic scleroderma	1.99e-05	0.000476	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.98e-05	0.000475	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—HSPG2—systemic scleroderma	1.91e-05	0.000457	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—CTGF—systemic scleroderma	1.82e-05	0.000435	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.81e-05	0.000433	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—EDN1—systemic scleroderma	1.77e-05	0.000425	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.54e-05	0.00037	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—HSPG2—systemic scleroderma	1.54e-05	0.000369	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—NOS3—systemic scleroderma	1.54e-05	0.000368	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—HSPG2—systemic scleroderma	1.51e-05	0.000361	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—CTGF—systemic scleroderma	1.45e-05	0.000347	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—NOS3—systemic scleroderma	1.4e-05	0.000334	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	1.33e-05	0.000319	CbGpPWpGaD
Miconazole—NOS2—Disease—TGFB1—systemic scleroderma	1.31e-05	0.000315	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—NOS3—systemic scleroderma	1.31e-05	0.000313	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—CCL2—systemic scleroderma	1.21e-05	0.000291	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—CTGF—systemic scleroderma	1.17e-05	0.00028	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—HSPG2—systemic scleroderma	1.16e-05	0.000279	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—CTGF—systemic scleroderma	1.14e-05	0.000274	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—HSPG2—systemic scleroderma	1.14e-05	0.000272	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—HSPG2—systemic scleroderma	1.07e-05	0.000256	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—HSPG2—systemic scleroderma	1.06e-05	0.000254	CbGpPWpGaD
Miconazole—NOS3—Disease—TGFB1—systemic scleroderma	1.02e-05	0.000245	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—HSPG2—systemic scleroderma	9.07e-06	0.000217	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—CTGF—systemic scleroderma	8.82e-06	0.000211	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—MMP9—systemic scleroderma	8.67e-06	0.000208	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—CTGF—systemic scleroderma	8.61e-06	0.000206	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—CTGF—systemic scleroderma	8.11e-06	0.000194	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—CTGF—systemic scleroderma	8.04e-06	0.000193	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—NOS3—systemic scleroderma	7.91e-06	0.00019	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—TGFB1—systemic scleroderma	7.14e-06	0.000171	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—HSPG2—systemic scleroderma	7e-06	0.000168	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—CTGF—systemic scleroderma	6.87e-06	0.000165	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—NOS3—systemic scleroderma	6.3e-06	0.000151	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—CTGF—systemic scleroderma	5.3e-06	0.000127	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—NOS3—systemic scleroderma	5.08e-06	0.000122	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—NOS3—systemic scleroderma	4.97e-06	0.000119	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—NOS3—systemic scleroderma	3.84e-06	9.2e-05	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—NOS3—systemic scleroderma	3.75e-06	8.98e-05	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—NOS3—systemic scleroderma	3.53e-06	8.46e-05	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—NOS3—systemic scleroderma	3.5e-06	8.39e-05	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—NOS3—systemic scleroderma	2.99e-06	7.17e-05	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—NOS3—systemic scleroderma	2.31e-06	5.53e-05	CbGpPWpGaD
